Analysis of adverse events with sclerosants reported to the United States Food and Drug Administration
Sign Up to like & getrecommendations! Published in 2022 at "Phlebology"
DOI: 10.1177/02683555221088373
Abstract: Objectives To analyze adverse events (AEs) related to sclerosants reported through the Federal Adverse Event Reporting System (FAERS). Methods We queried the FAERS database for all cases associated with sclerosants. Reports were analyzed and stratified… read more here.
Keywords: sclerosants reported; administration; analysis adverse; events sclerosants ... See more keywords